Imfinzi (durvalumab) - AstraZeneca, Celgene
Imfinzi: P2 data from P1/2 BEGONIA trial (NCT03742102) for 1L metastatic TNBC in H2 2020 (AstraZeneca) - Oct 24, 2019 - Q3 2019 Results: Data from P1/2 STUDY 1108 (NCT01693562) in advanced solid tumors in H2 2019 
P1/2 data • P2 data
https://www.astrazeneca.com/content/dam/az/PDF/2019/q3/Year-to-date_and_Q3_2019_Results_clinical_trials_appendix.pdf
 
Oct 24, 2019
 
 
486cefd0-f571-4866-8ebd-d060e34be306.jpg

3713c29a-eb3a-4872-9701-8d04198f2090.jpg